Insights

Strong R&D Focus Lundbeck's dedicated investment in neuroscience and neurology research positions it as a promising partner for innovative drug development collaborations and advanced technology integrations in brain health solutions.

Growing Market Presence With products available in over 80 countries and over 5,000 employees worldwide, Lundbeck demonstrates substantial global market reach that can be leveraged for distribution partnerships and regional sales expansion.

Emphasis on Digital Innovation The company's recent promotions of senior AI leadership and adoption of advanced tech stacks such as Snowflake and Power BI suggest a strong commitment to digital transformation, providing opportunities for data-driven sales strategies and AI-enabled solutions.

Recent Clinical Advancements Lundbeck's ongoing clinical trials and presentation of promising phase results for neurological condition treatments offer chances for medical supply companies, equipment vendors, and specialized service providers to engage in supporting their research initiatives.

Financial Stability and Growth With substantial revenue between $1 billion and $10 billion and recent funding of $566 million, Lundbeck has solid financial backing, indicating potential for high-value business partnerships in innovative pharmaceutical and tech procurement opportunities.

Similar companies to Lundbeck Pharmaceuticals Italy

Lundbeck Pharmaceuticals Italy Tech Stack

Lundbeck Pharmaceuticals Italy uses 8 technology products and services including Adobe, Power BI, Veeva Systems CRM, and more. Explore Lundbeck Pharmaceuticals Italy's tech stack below.

  • Adobe
    Audio, Video, Graphics
  • Power BI
    Business Intelligence
  • Veeva Systems CRM
    Customer Relationship Management
  • Snowflake
    Data Management Platforms
  • Ceridian
    Enterprise
  • Google
    Search Engines
  • Google Tag Manager
    Tag Management
  • Adobe Creative Suite
    Visualisation Software

Media & News

Lundbeck Pharmaceuticals Italy's Email Address Formats

Lundbeck Pharmaceuticals Italy uses at least 1 format(s):
Lundbeck Pharmaceuticals Italy Email FormatsExamplePercentage
FLast@lundbeck.comJDoe@lundbeck.com
69%
First.Last@lundbeck.comJohn.Doe@lundbeck.com
18%
Last.F@lundbeck.comDoe.J@lundbeck.com
8%
Last@lundbeck.comDoe@lundbeck.com
5%

Frequently Asked Questions

Where is Lundbeck Pharmaceuticals Italy's headquarters located?

Minus sign iconPlus sign icon
Lundbeck Pharmaceuticals Italy's main headquarters is located at 9 Ottiliavej Copenhagen, Hovedstaden 2500 Denmark. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is Lundbeck Pharmaceuticals Italy's stock symbol?

Minus sign iconPlus sign icon
Lundbeck Pharmaceuticals Italy is a publicly traded company; the company's stock symbol is LUN.CO.

What is Lundbeck Pharmaceuticals Italy's official website and social media links?

Minus sign iconPlus sign icon
Lundbeck Pharmaceuticals Italy's official website is lundbeck.com and has social profiles on LinkedInCrunchbase.

How much revenue does Lundbeck Pharmaceuticals Italy generate?

Minus sign iconPlus sign icon
As of May 2026, Lundbeck Pharmaceuticals Italy's annual revenue is estimated to be $5B.

What is Lundbeck Pharmaceuticals Italy's SIC code NAICS code?

Minus sign iconPlus sign icon
Lundbeck Pharmaceuticals Italy's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Lundbeck Pharmaceuticals Italy have currently?

Minus sign iconPlus sign icon
As of May 2026, Lundbeck Pharmaceuticals Italy has approximately 6K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Ceo At Lundbeck: U. W.Cio - Senior Vice President: C. T.Chief Commercial Officer: S. M.. Explore Lundbeck Pharmaceuticals Italy's employee directory with LeadIQ.

What industry does Lundbeck Pharmaceuticals Italy belong to?

Minus sign iconPlus sign icon
Lundbeck Pharmaceuticals Italy operates in the Pharmaceutical Manufacturing industry.

What technology does Lundbeck Pharmaceuticals Italy use?

Minus sign iconPlus sign icon
Lundbeck Pharmaceuticals Italy's tech stack includes AdobePower BIVeeva Systems CRMSnowflakeCeridianGoogleGoogle Tag ManagerAdobe Creative Suite.

What is Lundbeck Pharmaceuticals Italy's email format?

Minus sign iconPlus sign icon
Lundbeck Pharmaceuticals Italy's email format typically follows the pattern of FLast@lundbeck.com. Find more Lundbeck Pharmaceuticals Italy email formats with LeadIQ.

How much funding has Lundbeck Pharmaceuticals Italy raised to date?

Minus sign iconPlus sign icon
As of May 2026, Lundbeck Pharmaceuticals Italy has raised $566M in funding. The last funding round occurred on May 22, 2025 for $566M.

When was Lundbeck Pharmaceuticals Italy founded?

Minus sign iconPlus sign icon
Lundbeck Pharmaceuticals Italy was founded in 1915.

Lundbeck Pharmaceuticals Italy

Pharmaceutical ManufacturingHovedstaden, Denmark5001-10000 Employees

Lundbeck is a biopharmaceutical company focusing exclusively on brain health. With more than 70 years of experience in neuroscience, we are committed to improving the lives of people with neurological and psychiatric diseases.

Brain disorders affect a large part of the world’s population, and the effects are felt throughout society. With the rapidly improving understanding of the biology of the brain, we hold ourselves accountable for advancing brain health by curiously exploring new opportunities for treatments.

As a focused innovator, we strive for our research and development programs to tackle some of the most complex neurological challenges. We develop transformative medicines targeting people for whom there are few or no treatments available, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology.

We are committed to fighting stigma and we act to improve health equity. We strive to create long term value for our shareholders by making a positive contribution to patients, their families and society as a whole.

Lundbeck has more than 5,000 employees in more than 20 countries and our products are available in more than 80 countries. 

For additional information, we encourage you to visit our corporate site www.lundbeck.com

Section iconCompany Overview

Headquarters
9 Ottiliavej Copenhagen, Hovedstaden 2500 Denmark
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
Stock Symbol
LUN.CO
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1915
Employees
5001-10000

Section iconFunding & Financials

  • $566M

    Lundbeck Pharmaceuticals Italy has raised a total of $566M of funding over 2 rounds. Their latest funding round was raised on May 22, 2025 in the amount of $566M.

  • $1B$10B

    Lundbeck Pharmaceuticals Italy's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $566M

    Lundbeck Pharmaceuticals Italy has raised a total of $566M of funding over 2 rounds. Their latest funding round was raised on May 22, 2025 in the amount of $566M.

  • $1B$10B

    Lundbeck Pharmaceuticals Italy's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.